±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 520  |  »Ø¸´: 3

ÙóÓî΢·ç

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

[ÇóÖú] Çë½Ì΢¹Üµ°°×ʵÑé

tubulin protein assay
Õâ¸öʵÑéÔõô×ö°¡¡£¿´µÄÒ»¸öAMµÄÎÄÕÂ×öµÄ¼ì²âPTXµÄʵÑ飬ÓÐЩ²»Ã÷¡£Çó½Ì¡£
Relative activities of PTX were estimated by calculating the maximum rate of tubulin
protein polymerization relative to the standard samples (Figure S5). Stabilities of the free and
encapsulated PTX inside different types of NCs were evaluated by measuring the variations of
their activities using the tubulin assay after storage at 25 ¡ãC and 37 ¡ãC for 1¨C14 d in 96-well
microtiter plates according to previously established protocols. Briefly, at defined time
intervals, NCs were separated using centrifugation and redispersed in water at pH 4.5 to
extract PTX from NCs, and then PTX was separated using HPLC to perform a tubulin protein
assay. Then, select concentrations of PTX were reacted with tubulin protein solution (general
tubulin buffer, tubulin glycerol buffer, 1  mM GTP), and the reaction was followed by
measuring the increase in apparent absorption at 350 nm over a 1 h period at 37 ¡ãC using an
ELISA plate reader (Safire II, Tecan Sales Switzerland AG, Mannedorf, CH).  
As shown in Figure S5, drug degradation is generally considered as a first order process
and can be described by the following equation: ln(a/a0) = kt, where a is the activity of drug
at time t, a0 is the initial drug activity, k is the degradation rate constant. At half-life of drug
(t1/2), we have a=a0/2 =>  t1/2= 0.693/k => k=0.693/t1/2. The results of PTX half-life (t1/2) and
degradation rate constant (k) are shown in Figure S6 and Figure 3(a), respectively.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
ÄÑ

[ ·¢×ÔСľ³æ¿Í»§¶Ë ]
2Â¥2014-08-19 19:58:42
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÙóÓî΢·ç

ÖÁ×ðľ³æ (ÖøÃûдÊÖ)

¶¼Ã»ÈË´îÀíÂð£¿
3Â¥2014-09-05 13:12:40
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

xueqi95

гæ (СÓÐÃûÆø)

Â¥Ö÷£¬ÇëÎÊÄãÓõÄ΢¹Üµ°°×ÊÇ´ÓÄÄÀïÂòµÄ£¿
4Â¥2015-04-11 10:10:04
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÙóÓî΢·ç µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] ²ÄÁϹ¤³Ì322·Ö +5 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 5/250 2026-04-01 23:14 by ÎÞи¿É»÷111
[¿¼ÑÐ] 292·Ö£¬²ÄÁÏÓ뻯¹¤£¬ÉêÇëµ÷¼Á +18 ³ÌÇçÖ® 2026-04-01 20/1000 2026-04-01 23:01 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] Ò»Ö¾Ô¸ÉϺ£º£Ñó´óѧ083200ʳƷѧ˶£¬Çóµ÷¼Á£¬½ÓÊÜÆäËûרҵ +5 whatÕÅ 2026-04-01 5/250 2026-04-01 22:35 by guanxin1001
[¿¼ÑÐ] 085601²ÄÁϹ¤³ÌÕÒµ÷¼Á +20 oatmealR 2026-03-29 21/1050 2026-04-01 21:00 by lijunpoly
[¿¼ÑÐ] 320·Ö£¬²ÄÁÏÓ뻯¹¤×¨Òµ£¬Çóµ÷¼Á +14 Ò»¶¨Éϰ¶aaa 2026-03-27 18/900 2026-04-01 20:10 by »ý¼«µ÷¼ÁµÄСѧÉ
[¿¼ÑÐ] 379Çóµ÷¼Á +3 ?¿à¹Ï²»¿à 2026-04-01 3/150 2026-04-01 20:09 by ÄºÔÆÇ庮
[¿¼ÑÐ] 362Çóµ÷¼Á +13 Î÷ÄϽ»²ÄÁÏר˶3 2026-03-31 13/650 2026-04-01 17:38 by JYD2011
[¿¼ÑÐ] ×Ü·Ö343£¬ÇóÉúÎïѧµ÷¼Á +6 Éî¿ÌµÄ¿­Èö 2026-03-26 6/300 2026-04-01 15:58 by 2007huanle
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬335·Ö£¬0856£¬Çóµ÷¼ÁԺУºÍµ¼Ê¦ +11 Çã____Ïô 2026-03-27 12/600 2026-04-01 15:27 by oooqiao
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤µ÷¼ÁÒ»Ö¾Ô¸´óÁ¬º£ÊÂ085600£¬349 +9 ³ÔµÄ²»ÉÙ 2026-03-30 9/450 2026-04-01 11:24 by wangjy2002
[¿¼ÑÐ] »·¾³¹¤³Ì 085701£¬267Çóµ÷¼Á +15 minht 2026-03-29 16/800 2026-04-01 10:13 by li_sujuan99
[¿¼ÑÐ] 326Çóµ÷¼Á +4 áÌáÌ×Ð 2026-03-31 4/200 2026-04-01 09:58 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤ +15 Doleres 2026-03-31 16/800 2026-04-01 09:49 by lfj11
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +5 ÍÃͻͻͻ£¬ 2026-03-31 6/300 2026-04-01 09:37 by JourneyLucky
[¿¼ÑÐ] 352·Ö-085602-Ò»Ö¾Ô¸985 +6 º£Äɰٴ¨Ly 2026-03-29 6/300 2026-03-31 21:06 by yuq
[¿¼ÑÐ] ¿¼Ñе÷¼Á +9 СÀ¯ÐÂ±Ê 2026-03-29 10/500 2026-03-31 19:52 by Dyhoer
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +7 Ë«ÂíβƦÀϰå2 2026-03-31 7/350 2026-03-31 19:49 by Dyhoer
[¿¼ÑÐ] Ò»Ö¾Ô¸aÇø211£¬085601-307·ÖÇóµ÷¼Á +10 µ³¼ÎºÀ 2026-03-31 23/1150 2026-03-31 18:44 by JourneyLucky
[¿¼ÑÐ] 322Çóµ÷¼Á£ºÒ»Ö¾Ô¸ºþÄÏ´óѧ ²ÄÁÏÓ뻯¹¤£¨085600£©£¬ÒѹýÁù¼¶¡£ +10 XXСµË 2026-03-29 10/500 2026-03-31 16:46 by ²»³Ôô~µÄ؈
[¿¼ÑÐ] 085602 »¯¹¤×¨Ë¶ 338·Ö Çóµ÷¼Á +12 ·³ÕСç÷ 2026-03-27 12/600 2026-03-28 15:41 by L135790
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û